Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HSP70 Heat-Shock Proteins | 6 | 2023 | 393 | 1.610 |
Why?
|
Facial Transplantation | 5 | 2023 | 220 | 1.010 |
Why?
|
Molecular Chaperones | 6 | 2024 | 760 | 0.880 |
Why?
|
Graft Rejection | 12 | 2023 | 4504 | 0.870 |
Why?
|
Dendritic Cells | 6 | 2018 | 2747 | 0.740 |
Why?
|
Immunity, Humoral | 3 | 2022 | 608 | 0.680 |
Why?
|
Skin Transplantation | 2 | 2022 | 1097 | 0.650 |
Why?
|
Immunity, Innate | 4 | 2023 | 3077 | 0.620 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 93 | 0.600 |
Why?
|
Chemokines | 1 | 2022 | 962 | 0.580 |
Why?
|
T-Lymphocytes | 7 | 2023 | 10264 | 0.550 |
Why?
|
Heat-Shock Proteins | 4 | 2024 | 792 | 0.490 |
Why?
|
Receptors, Scavenger | 3 | 2023 | 123 | 0.490 |
Why?
|
Kidney Transplantation | 6 | 2023 | 4278 | 0.480 |
Why?
|
Immunity, Cellular | 3 | 2022 | 1560 | 0.470 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2024 | 3114 | 0.440 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2013 | 26 | 0.440 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 102 | 0.420 |
Why?
|
Scavenger Receptors, Class F | 3 | 2020 | 16 | 0.410 |
Why?
|
Interleukin-2 | 4 | 2024 | 1895 | 0.410 |
Why?
|
Th1 Cells | 2 | 2018 | 1040 | 0.390 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2021 | 4410 | 0.380 |
Why?
|
Melanoma, Experimental | 3 | 2014 | 557 | 0.370 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1442 | 0.370 |
Why?
|
Interleukin-17 | 2 | 2020 | 923 | 0.360 |
Why?
|
Heart Transplantation | 2 | 2021 | 3306 | 0.360 |
Why?
|
Graft Survival | 3 | 2024 | 3904 | 0.350 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 306 | 0.330 |
Why?
|
Interferon-gamma | 3 | 2018 | 3158 | 0.320 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1899 | 0.310 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2019 | 139 | 0.310 |
Why?
|
Interleukin-10 | 5 | 2018 | 1182 | 0.300 |
Why?
|
Antigens, CD | 1 | 2018 | 4032 | 0.290 |
Why?
|
Mycoplasma hyopneumoniae | 2 | 2017 | 2 | 0.280 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2020 | 366 | 0.240 |
Why?
|
Vaccines, Synthetic | 3 | 2022 | 620 | 0.230 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 22352 | 0.220 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 6222 | 0.210 |
Why?
|
Receptors, Purinergic P2X7 | 2 | 2013 | 86 | 0.200 |
Why?
|
Transplantation, Homologous | 5 | 2024 | 4860 | 0.200 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2022 | 422 | 0.200 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2022 | 382 | 0.200 |
Why?
|
STAT3 Transcription Factor | 2 | 2018 | 872 | 0.190 |
Why?
|
Lipopolysaccharides | 5 | 2022 | 2214 | 0.190 |
Why?
|
Purinergic P2Y Receptor Agonists | 1 | 2020 | 5 | 0.180 |
Why?
|
Chemokines, CC | 1 | 2022 | 285 | 0.180 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2020 | 18 | 0.180 |
Why?
|
Mice | 19 | 2024 | 81889 | 0.170 |
Why?
|
Scavenger Receptors, Class E | 1 | 2020 | 8 | 0.170 |
Why?
|
Antibodies, Viral | 5 | 2023 | 3212 | 0.170 |
Why?
|
Macrophages | 4 | 2016 | 5783 | 0.170 |
Why?
|
Lectins, C-Type | 1 | 2023 | 592 | 0.160 |
Why?
|
Animals | 24 | 2024 | 168930 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2020 | 474 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 478 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4349 | 0.150 |
Why?
|
Diet, Gluten-Free | 1 | 2021 | 285 | 0.150 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4215 | 0.150 |
Why?
|
Phagocytes | 1 | 2020 | 292 | 0.150 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 153 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2010 | 5143 | 0.150 |
Why?
|
Endocytosis | 2 | 2020 | 951 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.150 |
Why?
|
Pneumonia of Swine, Mycoplasmal | 1 | 2017 | 2 | 0.140 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2018 | 168 | 0.140 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 122 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 381 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1133 | 0.140 |
Why?
|
Skin | 2 | 2022 | 4499 | 0.140 |
Why?
|
Viral Matrix Proteins | 1 | 2018 | 193 | 0.140 |
Why?
|
Antigens, Ly | 1 | 2018 | 297 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 2 | 2013 | 347 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 2 | 2015 | 588 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1370 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 518 | 0.130 |
Why?
|
Organ Transplantation | 2 | 2024 | 1172 | 0.130 |
Why?
|
Mycoplasma | 1 | 2016 | 146 | 0.130 |
Why?
|
Granzymes | 1 | 2017 | 278 | 0.130 |
Why?
|
Membrane Proteins | 3 | 2018 | 7868 | 0.130 |
Why?
|
Bacterial Proteins | 4 | 2017 | 3833 | 0.120 |
Why?
|
Critical Illness | 3 | 2013 | 2750 | 0.120 |
Why?
|
Medicine | 1 | 2024 | 944 | 0.120 |
Why?
|
Mycobacterium tuberculosis | 3 | 2016 | 1911 | 0.120 |
Why?
|
Macrophage Activation | 2 | 2016 | 553 | 0.120 |
Why?
|
Cross-Priming | 1 | 2015 | 75 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 780 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 2010 | 0.120 |
Why?
|
Toll-Like Receptor 3 | 1 | 2014 | 98 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8621 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1794 | 0.110 |
Why?
|
Membrane Microdomains | 1 | 2015 | 205 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2016 | 685 | 0.110 |
Why?
|
Cytokines | 7 | 2021 | 7438 | 0.110 |
Why?
|
RNA, Double-Stranded | 1 | 2014 | 292 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2867 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1089 | 0.100 |
Why?
|
Survival Analysis | 3 | 2021 | 10100 | 0.100 |
Why?
|
Viral Vaccines | 1 | 2018 | 596 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1195 | 0.100 |
Why?
|
Cell Movement | 4 | 2022 | 5199 | 0.100 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 300 | 0.100 |
Why?
|
Dermatitis, Contact | 1 | 2013 | 134 | 0.100 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
Cells, Cultured | 5 | 2019 | 18984 | 0.100 |
Why?
|
Antigen Presentation | 2 | 2015 | 1250 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1027 | 0.090 |
Why?
|
Ovalbumin | 1 | 2013 | 677 | 0.090 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2232 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1814 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5861 | 0.090 |
Why?
|
Humans | 31 | 2024 | 766766 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1660 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1852 | 0.080 |
Why?
|
Synovial Fluid | 1 | 2010 | 391 | 0.080 |
Why?
|
Multiple Organ Failure | 1 | 2011 | 389 | 0.080 |
Why?
|
Apoptosis | 4 | 2017 | 9513 | 0.070 |
Why?
|
Adoptive Transfer | 1 | 2010 | 828 | 0.070 |
Why?
|
Antibody Formation | 2 | 2023 | 1392 | 0.070 |
Why?
|
Phagocytosis | 3 | 2021 | 1527 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2018 | 2978 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2022 | 17088 | 0.070 |
Why?
|
Transgenes | 1 | 2010 | 1014 | 0.070 |
Why?
|
Protein Engineering | 1 | 2010 | 554 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2012 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3792 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18330 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1491 | 0.070 |
Why?
|
Down-Regulation | 1 | 2013 | 2931 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2413 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9547 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2600 | 0.060 |
Why?
|
Female | 17 | 2022 | 396520 | 0.060 |
Why?
|
NF-kappa B | 3 | 2022 | 2493 | 0.060 |
Why?
|
Caspase 3 | 2 | 2017 | 730 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4049 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2020 | 10445 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1900 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2021 | 12791 | 0.050 |
Why?
|
Signal Transduction | 7 | 2021 | 23619 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6359 | 0.050 |
Why?
|
Untranslated Regions | 1 | 2022 | 30 | 0.050 |
Why?
|
Heat-Shock Response | 1 | 2024 | 179 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 61 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9515 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3738 | 0.050 |
Why?
|
Viral Structural Proteins | 1 | 2021 | 93 | 0.050 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 126 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2022 | 4652 | 0.050 |
Why?
|
Biology | 1 | 2024 | 292 | 0.050 |
Why?
|
Male | 15 | 2022 | 364142 | 0.050 |
Why?
|
Middle Aged | 10 | 2022 | 223257 | 0.050 |
Why?
|
Uridine Triphosphate | 1 | 2020 | 29 | 0.050 |
Why?
|
Chronic Disease | 2 | 2018 | 9357 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2022 | 520 | 0.040 |
Why?
|
Immune Tolerance | 2 | 2020 | 2325 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2022 | 3139 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4249 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2022 | 492 | 0.040 |
Why?
|
Neutrophils | 1 | 2013 | 3782 | 0.040 |
Why?
|
Tuberculosis | 1 | 2013 | 2011 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2015 | 1244 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1889 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5503 | 0.040 |
Why?
|
Germinal Center | 1 | 2022 | 379 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29948 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 250 | 0.040 |
Why?
|
Pilot Projects | 2 | 2023 | 8728 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 269 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39309 | 0.040 |
Why?
|
Retinal Dehydrogenase | 1 | 2018 | 78 | 0.040 |
Why?
|
Adult | 8 | 2022 | 223307 | 0.040 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 285 | 0.040 |
Why?
|
Isoantibodies | 1 | 2022 | 681 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2018 | 159 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1249 | 0.040 |
Why?
|
Vero Cells | 1 | 2018 | 486 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2018 | 697 | 0.030 |
Why?
|
Sepsis | 1 | 2011 | 2604 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2011 | 5343 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 13036 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 975 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 16044 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 245 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2022 | 1377 | 0.030 |
Why?
|
Interleukins | 1 | 2020 | 795 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4276 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 838 | 0.030 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2014 | 43 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 790 | 0.030 |
Why?
|
Poly I-C | 1 | 2014 | 110 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2016 | 14471 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
Arginase | 1 | 2014 | 81 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4114 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 2001 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3609 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2020 | 3093 | 0.030 |
Why?
|
Bacterial Vaccines | 1 | 2016 | 400 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1671 | 0.030 |
Why?
|
Croton Oil | 1 | 2013 | 3 | 0.030 |
Why?
|
Isoenzymes | 1 | 2018 | 1688 | 0.030 |
Why?
|
Virulence Factors | 1 | 2017 | 498 | 0.030 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2013 | 24 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2141 | 0.030 |
Why?
|
Clodronic Acid | 1 | 2013 | 60 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3624 | 0.030 |
Why?
|
Th2 Cells | 1 | 2018 | 1078 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1867 | 0.030 |
Why?
|
Lectins | 1 | 2014 | 490 | 0.030 |
Why?
|
Intestines | 1 | 2021 | 1904 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7585 | 0.020 |
Why?
|
Phenotype | 3 | 2016 | 16724 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3620 | 0.020 |
Why?
|
Species Specificity | 1 | 2016 | 2413 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1033 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1358 | 0.020 |
Why?
|
Alleles | 1 | 2013 | 6895 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2717 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2571 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2015 | 582 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2212 | 0.020 |
Why?
|
Cell Line | 2 | 2017 | 15563 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59939 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2013 | 794 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2392 | 0.020 |
Why?
|
Aged | 5 | 2022 | 171343 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1477 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5306 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65273 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3434 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8307 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4142 | 0.020 |
Why?
|
Child | 3 | 2022 | 80668 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59550 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1942 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3073 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74881 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3887 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42577 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1996 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2467 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2011 | 880 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7241 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4891 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4570 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1657 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2326 | 0.020 |
Why?
|
Lung | 2 | 2018 | 10067 | 0.020 |
Why?
|
Tetrazoles | 1 | 2013 | 923 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2013 | 1026 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54871 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5987 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40149 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6779 | 0.020 |
Why?
|
Pneumonia | 1 | 2018 | 2159 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6507 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1466 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5890 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4353 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1775 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88904 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9525 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9320 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5753 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15908 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11920 | 0.010 |
Why?
|
Pyridines | 1 | 2013 | 2888 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20144 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36461 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4344 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9461 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10860 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2009 | 3799 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15416 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18397 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11651 | 0.010 |
Why?
|
Aging | 1 | 2011 | 8731 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81635 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41710 | 0.000 |
Why?
|